INS and metabolic dysfunction-associated steatotic liver disease: Although some antioxidants, insulin sensitizers, and lipid-lowering drugs—such as vitamin E, metformin, thiazolidinediones, and statins—have been investigated and show a certain effect on reducing liver fat content and liver enzymes, improving partial liver histological lesions and lowering the score of NAFLD, they have no significance in alleviating liver fibrosis [12,13].